Cadent Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Buy
2,071
+11
+0.5% +$2.56K 0.11% 120
2026
Q1
$504K Sell
2,060
-203
-9% -$47.3K 0.13% 103
2025
Q4
$468K Sell
2,263
-12
-0.5% -$2.37K 0.12% 110
2025
Q3
$422K Buy
+2,275
New +$390K 0.11% 125
2024
Q2
Sell
-1,783
Closed -$282K 150
2024
Q1
$282K Buy
1,783
+2
+0.1% +$318 0.11% 103
2023
Q4
$279K Sell
1,781
-17
-0.9% -$2.61K 0.14% 90
2023
Q3
$280K Buy
1,798
+22
+1% +$3.63K 0.12% 86
2023
Q2
$294K Buy
1,776
+327
+23% +$52.8K 0.18% 90
2023
Q1
$225K Buy
1,449
+3
+0.2% +$484 0.1% 116
2022
Q4
$255K Buy
1,446
+122
+9% +$21.1K 0.13% 98
2022
Q3
$216K Buy
1,324
+9
+0.7% +$1.52K 0.12% 98
2022
Q2
$233K Sell
1,315
-165
-11% -$29.4K 0.13% 97
2022
Q1
$262K Buy
1,480
+280
+23% +$47.6K 0.12% 109
2021
Q4
$205K Sell
1,200
-79
-6% -$12.9K 0.09% 123
2021
Q3
$207K Hold
1,279
0.09% 123
2021
Q2
$211K Buy
1,279
+1
+0.1% +$166 0.09% 131
2021
Q1
$210K Buy
+1,278
New +$207K 0.09% 125

Other funds holding JNJ

Cadent Capital Advisors's JNJ Position: Q2 2026 in Review

Cadent Capital Advisors increased its Johnson & Johnson (JNJ) stake by 0.53% in Q2 2026, buying an estimated $2.56K and bringing the position to 2,071 shares worth $526K. The position accounts for 0.11% of the portfolio, ranked #120.

Cadent Capital Advisors first reported a position in JNJ in Q1 2021 and has held it in 17 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cadent Capital Advisors held 2,071 shares of Johnson & Johnson worth $526K as of Q2 2026.
  • Cadent Capital Advisors bought 11 Johnson & Johnson shares in Q2 2026, an estimated $2.56K.
  • Johnson & Johnson made up 0.11% of Cadent Capital Advisors's portfolio in Q2 2026, its #120 holding.
  • Cadent Capital Advisors first reported a position in Johnson & Johnson in Q1 2021 and has held it in 17 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cadent Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.